Work

Carbon quantum dot-based nanoplatforms for cancer therapy and photodynamic therapy: emerging strategies for targeting cancer and cancer stem cells

Year: 2026
Type: review
Abstract: With cancer's rising incidence and mortality rates expected to increase sharply by 2030, cancer continues to be a major worldwide health concern. Drug resistance, non-specific toxicity, and the persistence of cancer stem cells (CSCs), which cause tumor recurrence, metastasis, and therapeutic resistance, frequently limit conventional therapies. Although photodynamic therapy (PDT) provides a less intrusive option, tumor hypoxia, low photosensitizer (PS) selectivity, and restricted light penetration limit its therapeutic usefulness. Because of their remarkable optical characteristics, biocompatibility, adjustable surface chemistry, and inherent photosensitizing powers, carbon quantum dots (CQDs) have become a viable nanoplatform for cancer treatment. This review offers a comprehensive synthesis of current developments in CQD-based PDT for CSC and cancer cell targeting. The principles of PDT, CQD synthesis, and physicochemical characteristics; surface functionalization techniques using targeting ligands and stimuli-responsive moieties; and active targeting methods such as passive (enhanced permeability and retention (EPR) effect), active (ligand-receptor interactions), and organelle-specific targeting are all methodically examined. CQD-based methods for targeting CSC-like populations such as surface-functionalized CQDs for CSC indicators, ROS-mediated apoptosis, ferroptosis induction, and immunogenic cell death, are given particular attention. Highlighted are recent developments in upconversion systems, metal-doped hybrids, near-infrared (NIR)-activated CQDs, and combination treatments. However, direct experimental evidence that supports the efficacy of CQD-mediated PDT against CSCs remains limited, and most studies infer CSC-targeting potential from experiments conducted in cancer cell line. Challenges limiting the application of CQDs such as low quantum yield, tumor hypoxia, long-term biosafety, synthesis standardization, and clinical translation barriers were discussed, alongside emerging trends in personalized nanomedicine, AI-assisted design, and integration with gene therapy.
Language: English
Open Access status: gold
Estimated APC paid: $1,962
OpenAlex ID: W7225893320
FWCI:
Cites: 270
Cited by:
Related to: 10